1.
Imeta
; 3(3): e202, 2024 Jun.
Article
in English
| MEDLINE
| ID: mdl-38898988
ABSTRACT
The evaluation of pathobiome strains should be conducted at the strain level, involving the identification of the functional genes, while considering the impact of ecological niche and drug interactions. The safety, efficacy, and quality management of live biotherapeutic products (LBPs), especially pathobiome strains, have certain peculiarities. Promising development methods include the recombinant LBP and active metabolites.
2.
Front Immunol
; 13: 1069918, 2022.
Article
in English
| MEDLINE
| ID: mdl-36405699
3.